There are also studies on the use of MRI or PET to predict KRAS mutations in CRC; however, issues such as abdominal motion artefacts, high costs and ionizing radiation have greatly limited their clinical applications (12, 13). The gene discussed is KRAS; the disease is colorectal carcinoma.